Redefining reproductive health by developing cell-based therapeutics to treat and prevent conditions related to female infertility, egg aging, and menopause.

A daily non-hormonal contraceptive, birth control pill for men, the first ever.

A medical diagnostic platform designed to make pregnancy safe by delivering insights to moms and families.

Develops blood-based tests for early cancer detection focusing initially on ovarian cancer and lung cancers.

Developer of definitive tissue-based tests designed to diagnose and stage endometriosis.

Developer of AI-supported-enabled care platform designed to increase awareness by delivering instant analytics and evidence-based insights.

A digital health platform that aims to solve healthcare fragmentation by unifying patient data and streamlining access to care

Developer of RNA diagnostics tests intended to provide COVID-19, cancer, and residual disease detection.

FEMDX is a developer of cancer diagnosis devices designed to detect ovarian cancer.

Neuspera develops ultra-miniaturized, implantable medical devices for treating chronic conditions such as Overactive Bladder (OAB).

Simple Health Kit provides high-quality, accessible, and affordable diagnostic services for chronic health conditions.

Maude is setting new standards for sexual wellness and works closely with factories to create body-safe, accessible essentials for all.

A molecular diagnostics company at the intersection of epigenetics and AI tackling clinical problems such as infertility.

Attn Grace is a sustainable wellness brand designed for women, creating more sustainable solutions for women to combat bladder leakage.

Apollo Neuro offers a wearable consumer wellness device intended to help manage stress, challenging life transitions, and to promote a healthy lifestyle.